132 related articles for article (PubMed ID: 10083098)
1. Long-term follow-up of ABO-incompatible renal transplant recipients.
Karakayali H; Moray G; Demirağ A; Turan M; Bilgin N; Haberal M
Transplant Proc; 1999; 31(1-2):256-7. PubMed ID: 10083098
[No Abstract] [Full Text] [Related]
2. ABO-incompatible renal transplantation--dissociation of ABO antibodies.
Uchida K; Tominaga Y; Haba T; Katayama A; Ichimori T; Yamada K; Hibi Y; Oikawa T; Takeda A; Morozumi K; Takagi H
Transplant Proc; 1998 Aug; 30(5):2302-3. PubMed ID: 9723482
[No Abstract] [Full Text] [Related]
3. Significance of antidonor blood type antibody for long-term graft acceptance in ABO-incompatible kidney transplantation.
Hadano T; Ohara T; Aikawa A; Hasegawa A
Transplant Proc; 2000 Nov; 32(7):1847-9. PubMed ID: 11119966
[No Abstract] [Full Text] [Related]
4. A Comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation.
Gloor JM; Lager DJ; Fidler ME; Grande JP; Moore SB; Winters JL; Kremers WK; Stegall MD
Transplantation; 2005 Dec; 80(11):1572-7. PubMed ID: 16371928
[TBL] [Abstract][Full Text] [Related]
5. Relation between ABO blood type antigen and antibody and acute vascular rejection in ABO incompatible kidney transplantation.
Aikawa A; Hadano T; Ohara T; Hasegawa A; Yamashita M; Shindo M; Mizuiri T; Fushimi T; Sakai K; Hirayama N; Arai K; Tajima E
Transplant Proc; 1998 Nov; 30(7):3507-9. PubMed ID: 9838538
[No Abstract] [Full Text] [Related]
6. Graft survival rates in kidney transplant recipients of different blood groups.
Haberal M; Demirağ A; Moray G; Karakayali H; Akkoç H; Turan M; Bilgin N
Transplant Proc; 1998 May; 30(3):741-3. PubMed ID: 9595080
[No Abstract] [Full Text] [Related]
7. Tacrolimus therapy for ABO-incompatible kidney transplantation.
Takahashi K; Saito K; Sonda K; Nakagawa Y; Katagiri A; Tomita Y; Tanigawa T; Takeda M
Transplant Proc; 1998 Jun; 30(4):1219-20. PubMed ID: 9636495
[No Abstract] [Full Text] [Related]
8. Outcome of donor-specific skin graft is a reliable prognostic sign in ABO-incompatible live-donor renal transplants.
Haberal M; Tokyay R; Bilgin N
Transplant Proc; 1992 Dec; 24(6):2530-1. PubMed ID: 1465855
[No Abstract] [Full Text] [Related]
9. Transplantation of ABO-incompatible and living unrelated donor-recipient combinations.
Ishikawa N; Yagisawa T; Sakuma Y; Fujiwara T; Nukui A; Yashi M; Miyamoto N
Transplant Proc; 2008 Sep; 40(7):2292-3. PubMed ID: 18790215
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of tacrolimus in ABO-incompatible kidney transplantation: clinicopathological aspect of humoral rejection.
Saito K; Nakagawa Y; Tanikawa T; Sonda K; Nishi S; Yamaguchi Y; Arakawa M; Takahashi K
Transplant Proc; 1999 Nov; 31(7):2851-2. PubMed ID: 10578312
[No Abstract] [Full Text] [Related]
11. Successful results after 5 years of tacrolimus therapy in ABO-incompatible kidney transplantation in Japan.
Takahashi K; Takahara S; Uchida K; Yoshimura N; Toma H; Oshima S; Sonoda T;
Transplant Proc; 2005 May; 37(4):1800-3. PubMed ID: 15919471
[TBL] [Abstract][Full Text] [Related]
12. [The kidney transplantation from the ABO-incompatible donors].
Goriaĭnov VA; Kaabak MM; Babenko NN; Shishlo LA; Morozova MM; Ragimov AA; Dashkova NG; Salimov ÉL
Khirurgiia (Mosk); 2012; (7):70-4. PubMed ID: 22968508
[TBL] [Abstract][Full Text] [Related]
13. Findings of graft biopsy specimens within 90 days after ABO blood group incompatible living donor kidney transplantation compared with ABO-identical and non-identical transplantation.
Ushigome H; Okamoto M; Koshino K; Nobori S; Okajima H; Masuzawa N; Urasaki K; Yoshimura N
Clin Transplant; 2010 Jul; 24 Suppl 22():16-21. PubMed ID: 20590688
[TBL] [Abstract][Full Text] [Related]
14. Impact of positive PRA on the results of ABO-incompatible kidney transplantation.
Shimmura H; Tanabe K; Tokumoto T; Ishida H; Ishikawa N; Miyamoto N; Shimizu T; Shirakawa H; Setoguchi K; Toma H
Transplant Proc; 2004 Sep; 36(7):2169-71. PubMed ID: 15518789
[TBL] [Abstract][Full Text] [Related]
15. Kidney transplantation from spousal donors.
Kikuchi K; Narumi Y; Hama K; Iwamoto H; Uchiyama M; Kozaki K; Degawa H; Matsuno N; Kozaki M; Nagao T
Transplant Proc; 2000 Nov; 32(7):1817-8. PubMed ID: 11119951
[No Abstract] [Full Text] [Related]
16. ABO-incompatible living-donor kidney transplantation in children.
Shishido S; Asanuma H; Tajima E; Hoshinaga K; Ogawa O; Hasegawa A; Honda M; Nakai H
Transplantation; 2001 Sep; 72(6):1037-42. PubMed ID: 11579297
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.
Tanabe K; Takahashi K; Sonda K; Tokumoto T; Ishikawa N; Kawai T; Fuchinoue S; Oshima T; Yagisawa T; Nakazawa H; Goya N; Koga S; Kawaguchi H; Ito K; Toma H; Agishi T; Ota K
Transplantation; 1998 Jan; 65(2):224-8. PubMed ID: 9458019
[TBL] [Abstract][Full Text] [Related]
18. A 16-year experience with 1275 primary living donor kidney transplants: univariate and multivariate analysis of risk factors affecting graft survival.
Park K; Kim YS; Kim MS; Kim SI; Oh CK; Han DS; Lee HY; Choi KH; Kim PK
Transplant Proc; 1996 Jun; 28(3):1578-9. PubMed ID: 8658792
[No Abstract] [Full Text] [Related]
19. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
Han S; Hwang E; Park S; Park U; Kim H; Cho W
Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367
[TBL] [Abstract][Full Text] [Related]
20. Conversion of stable ABO-incompatible kidney transplant recipients from mycophenolate mofetil with standard exposure calcineurin inhibitors (CNIs) to everolimus with very low exposure CNIs-a short-term pilot study.
Uchida J; Machida Y; Iwai T; Kuwabara N; Kabei K; Naganuma T; Kumada N; Kawashima H; Nakatani T
Clin Transplant; 2014 Jan; 28(1):80-7. PubMed ID: 24329776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
